STOCK TITAN

VolitionRx (VNRX) EPS by Year

VNRX NYSE

VolitionRx Limited does not report diluted earnings per share for fiscal year 2025, so the figure is not reported on this page. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters VolitionRx Limited has filed alongside them.

FY2025 annual
EPS (Diluted) N/A
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

VNRX EPS (Diluted) by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
EPS (Diluted)N/A-$6.20n/m-$10.00N/A-$10.20n/m-$9.00n/m-$8.20n/m-$11.40n/m-$11.20n/m-$10.40n/m-$10.80n/m-$12.20n/m-$6.80n/m-$8.80-$9.00

VNRX EPS (Diluted) by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
EPS (Diluted)-$0.21-$0.85-$0.97n/mN/A-$0.99n/m-$1.22n/m-$1.12n/m-$1.20-$1.40-$1.60-$2.00N/A

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More VolitionRx Limited financials

Frequently Asked Questions

VolitionRx Limited does not report diluted earnings per share for fiscal year 2025, so the figure is not reported on this page.

VolitionRx Limited (VNRX) reported -$0.21 in diluted earnings per share in Q3 2026.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what VolitionRx Limited (VNRX) reported on that line in every period on record.